Patients Face New Barriers for GLP-1 Drugs Like Wegovy and Ozempic
Even With Lower Prices, Medicare, Medicaid, and Other Insurers Tighten Coverage for Drugs Like Mounjaro and Zepbound Using Prior Authorization and Other Tools
Blog Post
The federal government wants 80% of kidney disease patients to get dialysis at home or receive an organ transplant by 2025. Currently, only 13.7% of Americans who use dialysis services do so at home.
With such a large gap, LDI Senior Fellows Yuvaram Reddy, Robert Burke, Peter Reese, and Meghan Lane-Fall reviewed survey responses from more than 500 patients, caregivers, and providers—and identified the most significant barriers for home dialysis.
Getting the treatment at home offers significant benefits for patients, but it has a consistently low adoption rate. Here’s what is holding everyone back.
Barriers for Patients and Care Partners:
Barriers for Health Care Providers:
5. Lack of Reimbursable Mechanisms for Support
6. Lack of Experienced Home Dialysis Staff
Addressing these barriers requires a multifaceted approach that includes improving patient education, enhancing support systems at home and from providers, and developing policies that support the financial and staffing needs of home dialysis programs. By tackling these challenges, we can improve the adoption and effectiveness of home dialysis.
The study, “Identifying Major Barriers to Home Dialysis (the IM-HOME Study): Findings from a National Survey of Patients, Care Partners, and Providers,” was published on June 6, 2024 in the American Journal of Kidney Diseases. Authors include Yuvaram Reddy, Matthew D. Kearney, Michaela Ward, Robert Burke, Ann M. O’Hare, Peter Reese, and Meghan Lane-Fall.

Even With Lower Prices, Medicare, Medicaid, and Other Insurers Tighten Coverage for Drugs Like Mounjaro and Zepbound Using Prior Authorization and Other Tools
A 2024 Study Showing How Even Small Copays Reduce PrEP Use Fueled Media, Legal, and Advocacy Efforts As Courts Weighed a Case Threatening No-Cost Preventive Care for Millions
Chart of the Day: LDI Researchers Report Major Coverage Differences Across ACA and Medicaid Plans, Affecting Access to Drugs That Treat Chemo-Related Nausea
Insurers Avoid Counties With Small Populations and Poor Health but a New LDI Study Finds Limited Evidence of Anticompetitive Behavior
A Proven, Low-Risk Treatment Is Backed by Major Studies and Patient Demand, Yet Medicare and Insurers Still Make It Hard To Use
Chart of the Day: Medicare-Medicaid Plans—Created to Streamline Care for Dually Eligible Individuals—Failed to Increase Medicaid Participation in High-Poverty Communities